Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Capricor Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Filing Fee

Previously

Paid In

Connection

with

Fee

Proposed

Carry

Unsold

Calculation

Maximum

Maximum

Carry

Carry

Forward

Securities

Security

or Carry

Offering

Aggregate

Amount of

Forward

Forward

Initial

to be

Security

Class

Forward

Amount

Price Per

Offering

Fee

Registration

Form

File

Effective

Carried

Type

Title

Rule

Registered

Unit

Price

Rate

Fee

Type

Number

date

Forward

Newly Registered Securities

Fees to Be Paid

Equity

(1)(2)

(1)

(3)

$0.001 per share

Equity

Preferred Stock, par value

(1)(2)

(1)

(3)

$0.001 per share

Debt

Debt Securities

(1)

(1)

(3)

Other

Warrants

(1)

(1)

(3)

Other

Units

(1)

(1)

(3)

Unallocated

—

Rule

(1)(2)

(1)

$

81,987,348.65 (3)

$

0.0001531

$

12,552.26 (4)

(Universal)

457(o)

Shelf

Fees Previously Paid

Equity

$0.001 per share

Equity

Preferred Stock, par value
$0.01 per share

Debt

Debt Securities

Other

Warrants

Other

Units

Unallocated (Universal) Shelf

—

457(o)

$

44,145,686

$

6,515.90

Carry Forward Securities

Carry

Unallocated

—

Rule 415(a)(6)

$

23,866,966.44

S-3

333-254363

6/16/2021

$

2,603.89

Forward

(Universal)

Securities (5)

Shelf

Total Offering Amounts

$

150,000,000

$

19,068.16

Total Fees Previously Paid (6)

$

6,515.90

Total Fee Offsets

$

—

Net Fee Due

$

12,552.26


(1)	An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities.

(2)	Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(3)	Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $150,000,000.

(4)	The registration fee has been calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended.

(5)	An aggregate of $2,603.89 of the amount of the registration fee was previously paid in connection with the unissued securities registered under the Registrant’s registration statement on Form S-3 (File No. 333-254363) initially filed on March 16, 2021 (the “Prior Registration Statement”). $23,866,966.44 of securities remain unsold under the Prior Registration Statement. The Registrant is allowed to apply $2,603.89 toward the registration fee for this registration statement in reliance on Rule 415(a)(6), because $23,866,966.44 of unsold securities (and associated fees) are being moved from the Prior Registration Statement to this registration statement. Pursuant to Rule 415(a)(6), the $2,603.89 registration fee previously paid by the Registrant relating to the unsold securities included on this registration statement will continue to be applied to such unsold securities.

(6)	$6,515.90 of the registration fee was previously paid in connection with the prior filing of this registration statement.